http://www.bing.com:80/search?q=Small+Blue+LED+BulbSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Small+Blue+LED+BulbCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://advanced.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adfm.202470052A Small‐Molecule Polycationic Crosslinker Boosts Alginate‐Based Bioinks for Extrusion Bioprinting (Adv. Funct. Mater. 9/2024) www.afm-journal.deThu, 19 Jun 2025 07:30:00 GMThttps://nsojournals.onlinelibrary.wiley.com/doi/epdf/10.1002/ecog.08112Algorithm performance: small sample sizes As model performance is expected to increase with sample size (Moudrý et al. 2024) and we were especially interested in modeling species with small sample sizes, we conducted a second comparison for the subset of species with 20 or fewer occurrence records.Mon, 20 Apr 2026 12:34:00 GMThttps://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17814The purpose of this guideline is to provide advice, based on the best evidence available, to guide clinicians regarding the investigation and care of the small-for-gestational-age (SGA) fetus and growth restricted fetus.Wed, 22 Apr 2026 18:36:00 GMThttps://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/adma.72464Physical Intelligence in Small‐Scale Robots and Machines (Adv. Mater. 12/2026) Vol. 38 . No. 12 . February 25 . 2016 www.advmat.deFri, 03 Apr 2026 12:32:00 GMThttps://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cbic.202500156Methods for Controlling Small GTPase Activity Benjamin Faulkner, Yuchen He, Daniel Sitrin, and Cliff I. Stains* Small GTPases comprise a diverse class of signaling proteins in mammalian cells and regulate a variety of cellular processes such as cell growth, cell movement, vesicle formation, and nuclear transport.Tue, 21 Apr 2026 11:57:00 GMThttps://onlinelibrary.wiley.com/doi/epdf/10.1002/smll.202508637Small published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Tue, 07 Apr 2026 04:50:00 GMThttps://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.202501476RUsing small molecules rather than relying on PTMs to directly target and regulate condensates presents potential for breakthroughs in the treatment and prevention of diseases presenting with aberrant phase separation. This in turn depends on the development of simple, yet effective, approaches to discover and test highly efficient compounds.Sat, 18 Apr 2026 12:43:00 GMThttps://ifst.onlinelibrary.wiley.com/doi/pdf/10.1111/ijfs.14048Figure 3 Factors affecting the absorption of small peptides. Food and non-food factors could affect the absorption of small peptides poten-tially via (1) competitive inhibition of PepT1, (2) transcriptional regulation of PepT1 and (3) maintenance of the proton gradient (a driving force for PepT1-mediated transport).Thu, 19 Mar 2026 12:29:00 GMThttps://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.35778INTRODUCTION Molecular classification of non–small cell lung cancer (NSCLC) has introduced the era of precision oncology that improved clinical out-comes with targeted therapies. The most common genetic mutation is activation of the epidermal growth factor receptor (EGFR), which occurs in about 14%–46% of patients diagnosed with NSCLC and is more frequent in females, nonsmokers, and Asians ...Wed, 22 Apr 2026 16:13:00 GMThttps://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202500258Balinatunfib (also known as SAR441566) is an orally available small molecule designed to exploit this mechanism, thereby preventing TNF from effectively binding to its receptors. In α preclinical models, balinatunfib reduces inflammation compara-bly to biologic therapies, yet avoids the complexities of large pro-tein therapeutics.Thu, 23 Apr 2026 13:27:00 GMT